Female
Multidisciplinary Team(s)
Head Neck Oncology
Melanoma/Skin
Thoracic Oncology
Department/Research Program(s)
Dept of Oncology
Cancer Type(s)
Hypopharynx (pyriform Sinus)
Laryngeal Cancer
Lip/Oral Cavity (hard palate
Lung Cancer (Small Cell Non-Small Cell)
Melanoma
Merkel Cell Carcinoma
Neck Cancer
Nose Cancer
Oral Cavity Cancer (Mouth)
Oropharynx (soft palate
Sinus Cancer
Skin Cancer (Basal Squamous Cell)
Throat Cancer
Thymus Gland Cancer
Thyroid Cancer
Contact Info
Email:
weisea@karmanos.org
Education
Fellowship
Hematology/Oncology, Karmanos Cancer Institute
Medical School
Michigan State University, College of Osteopathic Medicine
Residency
Internal Medicine, Eastern Virginia Medical School
Professional Memberships/Associations
AOA
AMA
ASCO
Board Certifications
American Board Certified, Internal Medicine
American Board Certified, Medical Oncology
Clinical Interests
Medical oncology Clinical Research
Research Interests
Scientific research aimed at harnessing the bodies own immune system to combat the initiation and spread of cancer. Multidisciplinary care of patients with breast cancer.
Profile
I am a native of Michigan, attended Alma College for undergraduate education, then Michigan State University for medical school. Following medical school, I served in the Navy for 5 years as a general medical officer. After military service, I completed my Internal Medicine Residency at EVMS in Norfolk, then returned to Michigan for Hematology/oncology Fellowship. I have spent 3 years in a research lab with Dr. Wei, investigating a DNA vacciine for Her2 positive breast cancer. I have worked in several fields of Oncology, including Phase I clinical trials with Dr. LoRusso. Currently, I am working with the Thoracic team, the Head Neck team, and the Melanoma team to provide state of the art oncology care and clinical trial research.
Publications
Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity. Cancer Immunology and Immunotherapy. Assisted with laboratory experiments. Contributed to content and editing of final paper. October 3, 2008. [Epub ahead of print]. Authors: Whittington, P.J., Radkovich-Brown, O., Jacob, J.B., Jones, R.F., Weise, A.M., Wei, W.Z.
expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat. 2009 Mar 24. Authors: Fu, J., Weise, A.M., Falany, J.L., Falany, C.N., Thibodeau, B.J., Miller, F.R., Kocarek, T.A., Runge-Morris, M.
Fatal Liver Failure in a Patient on Acetaminophen Treated with the Tyrosine Kinase Inhibitor Sunitinib Malate. The Annals of Pharmacotherapy April 2009. Authors: Weise, A.M., Chin, L., Shields, A.F.
Combining Human and Rat Sequences in Her-2 DNA Vaccines Blunts Immune Tolerance and Drives Antitumor Immunity. Cancer Res. 2010. Authors: Jacob, J.B., Quaglino, E., Radkevich-Brown, O., Jones, R.F., Piechocki, M.P., Reyes, J.D., Weise, A.M., Amici, A., Wei, W.
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression, Cancer Immunol Immunother, 2010 Mar;59(3):409-17. PMID: 19730859 Authors: Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ.
